Evaluation of the TMPRSS2:ERG fusion gene, PTEN, the Prolaris test, the Decipher test, and the Oncotype DX Genomic Prostate Score can also provide important information helping improve the individual management for PCa patients (51). This evidence concerns the gene PTEN and posterior cortical atrophy.